Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin melt in pediatric bedwetting (DRY)
NCT00230594Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jul 2004
- Primary completion
- Jan 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nocturnal enuresis (NE) comparing Desmopressin with Placebo (2 arms). Primary endpoint: Number of wet nights at 54 days. Started Jul 2004; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT00230594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230594.